EdgarLookup

Albertsons Companies, Inc. — Financial Data

Annual figures from SEC EDGAR XBRL filings (10-K)

These figures are extracted directly from XBRL-tagged financial statements that Albertsons Companies, Inc. filed with the SEC as part of its annual 10-K reports. XBRL (eXtensible Business Reporting Language) is a structured data format the SEC requires for machine-readable financial disclosures. Values shown are as reported — negative figures indicate a loss and are shown in red.

Overview All Filings Annual Quarterly Insiders
1.2%
Profit Margin
Net income ÷ revenue
3.6%
Return on Assets
Net income ÷ assets
+1.5%
Revenue Growth
Year over year

Revenue

Revenue recognized from contracts with customers under ASC 606, excluding taxes collected on behalf of government authorities. This is the primary revenue concept for many companies.

Fiscal Year Period End Value Filed
FY2024 Feb 22, 2025 $80.39B Apr 21, 2025
FY2024 Feb 24, 2024 $79.24B Apr 21, 2025
FY2024 Feb 25, 2023 $77.65B Apr 21, 2025
FY2023 Feb 26, 2022 $71.89B Apr 22, 2024
FY2021 Feb 27, 2021 $15.77B Apr 28, 2021
FY2021 Dec 5, 2020 $15.41B Apr 28, 2021
FY2021 Sep 12, 2020 $15.76B Apr 28, 2021
FY2021 Jun 20, 2020 $22.75B Apr 28, 2021
FY2021 Feb 29, 2020 $1.10B Apr 28, 2021
FY2021 Nov 30, 2019 $14.10B Apr 28, 2021

Revenue (Net Sales)

Net sales revenue — gross revenue less returns, allowances, and discounts. Used by many manufacturers and retailers as the primary top-line figure.

Fiscal Year Period End Value Filed
FY2017 Feb 24, 2018 $14.03B May 11, 2018
FY2017 Dec 2, 2017 $13.60B May 11, 2018
FY2017 Sep 9, 2017 $13.83B May 11, 2018
FY2017 Jun 17, 2017 $18.46B May 11, 2018
FY2017 Feb 25, 2017 $13.82B May 11, 2018
FY2017 Dec 3, 2016 $13.61B May 11, 2018
FY2017 Sep 10, 2016 $13.86B May 11, 2018
FY2017 Jun 18, 2016 $18.39B May 11, 2018
FY2017 Feb 27, 2016 $58.73B May 11, 2018

Gross Profit

Revenue minus the cost of goods sold (COGS). Gross profit shows how much revenue remains to cover operating expenses, R&D, and administrative costs before calculating operating income.

Fiscal Year Period End Value Filed
FY2024 Feb 22, 2025 $22.26B Apr 21, 2025
FY2024 Feb 24, 2024 $22.05B Apr 21, 2025
FY2024 Feb 25, 2023 $21.76B Apr 21, 2025
FY2023 Feb 26, 2022 $20.72B Apr 22, 2024
FY2021 Feb 27, 2021 $4.56B Apr 28, 2021
FY2021 Dec 5, 2020 $4.51B Apr 28, 2021
FY2021 Sep 12, 2020 $4.57B Apr 28, 2021
FY2021 Jun 20, 2020 $6.77B Apr 28, 2021
FY2021 Feb 29, 2020 $4.42B Apr 28, 2021
FY2021 Nov 30, 2019 $4.00B Apr 28, 2021

Net Income

The bottom-line profit — what remains after all operating expenses, interest, taxes, and other costs are deducted. A negative value means the company reported a net loss for the year.

Fiscal Year Period End Value Filed
FY2024 Feb 22, 2025 $958.60M Apr 21, 2025
FY2024 Feb 24, 2024 $1.30B Apr 21, 2025
FY2024 Feb 25, 2023 $1.51B Apr 21, 2025
FY2023 Feb 26, 2022 $1.62B Apr 22, 2024
FY2021 Feb 27, 2021 ($144.20M) Apr 28, 2021
FY2021 Dec 5, 2020 $123.70M Apr 28, 2021
FY2021 Sep 12, 2020 $284.50M Apr 28, 2021
FY2021 Jun 20, 2020 $586.20M Apr 28, 2021
FY2021 Feb 29, 2020 $67.80M Apr 28, 2021
FY2021 Nov 30, 2019 $54.80M Apr 28, 2021

Operating Income

Profit from core business operations before interest expense and income taxes (also known as EBIT). Excludes non-operating items, making it a cleaner measure of operational efficiency than net income.

Fiscal Year Period End Value Filed
FY2024 Feb 22, 2025 $1.55B Apr 21, 2025
FY2024 Feb 24, 2024 $2.07B Apr 21, 2025
FY2024 Feb 25, 2023 $2.31B Apr 21, 2025
FY2023 Feb 26, 2022 $2.44B Apr 22, 2024
FY2021 Feb 27, 2021 ($174.80M) Apr 28, 2021
FY2021 Dec 5, 2020 $258.50M Apr 28, 2021
FY2021 Sep 12, 2020 $562.00M Apr 28, 2021
FY2021 Jun 20, 2020 $971.80M Apr 28, 2021
FY2021 Feb 29, 2020 $326.60M Apr 28, 2021
FY2021 Nov 30, 2019 $206.60M Apr 28, 2021

SG&A Expense

Selling, general, and administrative expenses — the overhead costs of running the business, including salaries, marketing, legal fees, and corporate office costs. Excludes COGS and R&D.

Fiscal Year Period End Value Filed
FY2024 Feb 22, 2025 $20.61B Apr 21, 2025
FY2024 Feb 24, 2024 $19.93B Apr 21, 2025
FY2024 Feb 25, 2023 $19.60B Apr 21, 2025
FY2023 Feb 26, 2022 $18.30B Apr 22, 2024
FY2022 Feb 27, 2021 $18.84B Apr 25, 2023
FY2022 Feb 29, 2020 $16.64B Apr 26, 2022
FY2021 Feb 23, 2019 $16.27B Apr 28, 2021
FY2019 Feb 24, 2018 $16.21B Aug 7, 2020
FY2018 Feb 25, 2017 $16.03B Apr 24, 2019
FY2017 Feb 27, 2016 $15.66B May 11, 2018

Operating Cash Flow

Cash generated from core business operations — a more reliable measure of financial health than net income because it strips out non-cash items like depreciation and one-time charges.

Fiscal Year Period End Value Filed
FY2024 Feb 22, 2025 $2.68B Apr 21, 2025
FY2024 Feb 24, 2024 $2.66B Apr 21, 2025
FY2024 Feb 25, 2023 $2.85B Apr 21, 2025
FY2023 Feb 26, 2022 $3.51B Apr 22, 2024
FY2022 Feb 27, 2021 $3.90B Apr 25, 2023
FY2022 Feb 29, 2020 $1.90B Apr 26, 2022
FY2021 Feb 23, 2019 $1.69B Apr 28, 2021
FY2019 Feb 24, 2018 $1.02B Aug 7, 2020
FY2018 Feb 25, 2017 $1.81B Apr 24, 2019
FY2017 Feb 27, 2016 $901.60M May 11, 2018

Capital Expenditures (Capex)

Cash spent on acquiring or upgrading physical assets — property, equipment, and infrastructure. High capex businesses include manufacturing, telecom, and energy companies.

Fiscal Year Period End Value Filed
FY2021 Feb 27, 2021 $1.64B Apr 28, 2021
FY2021 Feb 29, 2020 $1.47B Apr 28, 2021
FY2021 Feb 23, 2019 $1.34B Apr 28, 2021
FY2019 Feb 24, 2018 $1.52B Aug 7, 2020
FY2018 Feb 25, 2017 $1.38B Apr 24, 2019
FY2017 Feb 27, 2016 $911.70M May 11, 2018

Total Assets

The total value of everything the company owns or controls — cash, investments, receivables, property, equipment, and intangibles. Reported as of fiscal year end.

Fiscal Year Period End Value Filed
FY2024 Feb 22, 2025 $26.76B Apr 21, 2025
FY2024 Feb 24, 2024 $26.22B Apr 21, 2025
FY2023 Feb 25, 2023 $26.17B Apr 22, 2024
FY2022 Feb 26, 2022 $28.12B Apr 25, 2023
FY2022 Feb 27, 2021 $26.60B Apr 26, 2022
FY2021 Feb 29, 2020 $24.74B Apr 28, 2021
FY2019 Feb 23, 2019 $20.78B Aug 7, 2020
FY2018 Feb 24, 2018 $21.81B Apr 24, 2019
FY2017 Feb 25, 2017 $23.76B May 11, 2018

Stockholders Equity

The net worth attributable to shareholders: total assets minus total liabilities. Also called book value. Can be negative if liabilities exceed assets, which is common in capital-intensive industries.

Fiscal Year Period End Value Filed
FY2024 Feb 22, 2025 $3.39B Apr 21, 2025
FY2024 Feb 24, 2024 $2.75B Apr 21, 2025
FY2024 Feb 25, 2023 $1.61B Apr 21, 2025
FY2024 Feb 26, 2022 $3.02B Apr 21, 2025
FY2023 Feb 27, 2021 $1.32B Apr 22, 2024
FY2022 Feb 29, 2020 $2.28B Apr 25, 2023
FY2022 Feb 23, 2019 $1.45B Apr 26, 2022
FY2021 Feb 24, 2018 $1.40B Apr 28, 2021

Goodwill

An intangible asset representing the premium paid above fair value when acquiring another company. A large goodwill balance signals a history of acquisitions at premium prices.

Fiscal Year Period End Value Filed
FY2024 Feb 22, 2025 $1.20B Apr 21, 2025
FY2024 Feb 24, 2024 $1.20B Apr 21, 2025
FY2023 Feb 25, 2023 $1.20B Apr 22, 2024
FY2022 Feb 26, 2022 $1.20B Apr 25, 2023
FY2022 Feb 27, 2021 $1.18B Apr 26, 2022
FY2021 Feb 29, 2020 $1.18B Apr 28, 2021
FY2019 Feb 23, 2019 $1.18B Aug 7, 2020
FY2018 Feb 24, 2018 $1.18B Apr 24, 2019
FY2018 Feb 25, 2017 $1.17B Apr 24, 2019
FY2017 Feb 27, 2016 $1.13B May 11, 2018

Retained Earnings

Cumulative net income kept by the company rather than distributed as dividends. A growing retained earnings balance indicates consistent profitability; a deficit indicates cumulative losses.

Fiscal Year Period End Value Filed
FY2024 Feb 22, 2025 $1.49B Apr 21, 2025
FY2024 Feb 24, 2024 $828.20M Apr 21, 2025
FY2023 Feb 25, 2023 ($185.00M) Apr 22, 2024
FY2022 Feb 26, 2022 $2.56B Apr 25, 2023
FY2022 Feb 27, 2021 $1.26B Apr 26, 2022
FY2021 Feb 29, 2020 $592.30M Apr 28, 2021
FY2019 Feb 23, 2019 ($431.80M) Aug 7, 2020
FY2018 Feb 24, 2018 ($569.00M) Apr 24, 2019
FY2017 Feb 25, 2017 ($615.30M) May 11, 2018

Cash & Equivalents

Highly liquid assets the company holds — cash on hand, bank balances, and short-term investments with maturities of three months or less. A key indicator of short-term financial health.

Fiscal Year Period End Value Filed
FY2024 Feb 22, 2025 $293.60M Apr 21, 2025
FY2024 Feb 24, 2024 $188.70M Apr 21, 2025
FY2023 Feb 25, 2023 $455.80M Apr 22, 2024
FY2022 Feb 26, 2022 $2.90B Apr 25, 2023
FY2022 Feb 27, 2021 $1.72B Apr 26, 2022
FY2021 Feb 29, 2020 $470.70M Apr 28, 2021
FY2019 Feb 23, 2019 $926.10M Aug 7, 2020
FY2018 Feb 24, 2018 $670.30M Apr 24, 2019
FY2018 Feb 25, 2017 $1.22B Apr 24, 2019
FY2017 Feb 27, 2016 $579.70M May 11, 2018

Long-Term Debt

Debt obligations due more than one year from the balance sheet date — bonds, term loans, and notes payable. High long-term debt relative to equity can signal elevated financial leverage.

Fiscal Year Period End Value Filed
FY2019 Feb 23, 2019 $10.59B Aug 7, 2020
FY2018 Feb 24, 2018 $11.01B Apr 24, 2019
FY2017 Feb 25, 2017 $11.38B May 11, 2018

EPS (Basic)

Net income divided by the weighted average shares outstanding. Basic EPS does not account for dilutive securities like options or convertible bonds — use diluted EPS for a more conservative view.

Fiscal Year Period End Value Filed
FY2024 Feb 22, 2025 1 Apr 21, 2025
FY2024 Feb 24, 2024 2 Apr 21, 2025
FY2024 Feb 25, 2023 2 Apr 21, 2025
FY2023 Feb 26, 2022 2 Apr 22, 2024
FY2021 Feb 27, 2021 0 Apr 28, 2021
FY2021 Dec 5, 2020 0 Apr 28, 2021
FY2021 Sep 12, 2020 0 Apr 28, 2021
FY2021 Jun 20, 2020 1 Apr 28, 2021
FY2022 Feb 29, 2020 0 Apr 26, 2022
FY2021 Feb 23, 2019 0 Apr 28, 2021

EPS (Diluted)

Net income divided by the fully diluted share count — including all potential shares from options, warrants, and convertible instruments. The more conservative and widely cited EPS figure.

Fiscal Year Period End Value Filed
FY2024 Feb 22, 2025 1 Apr 21, 2025
FY2024 Feb 24, 2024 2 Apr 21, 2025
FY2024 Feb 25, 2023 2 Apr 21, 2025
FY2023 Feb 26, 2022 2 Apr 22, 2024
FY2021 Feb 27, 2021 0 Apr 28, 2021
FY2021 Dec 5, 2020 0 Apr 28, 2021
FY2021 Sep 12, 2020 0 Apr 28, 2021
FY2021 Jun 20, 2020 1 Apr 28, 2021
FY2022 Feb 29, 2020 0 Apr 26, 2022
FY2021 Feb 23, 2019 0 Apr 28, 2021

Shares Outstanding

Total common shares issued and held by all shareholders, excluding treasury shares. Combined with market price gives market capitalization.

Fiscal Year Period End Value Filed
FY2019 Feb 29, 2020 277.88M Aug 7, 2020
FY2019 Feb 23, 2019 277.88M Aug 7, 2020
FY2018 Feb 24, 2018 279.65M Apr 24, 2019

Dividends Paid

Cash dividends distributed to common shareholders during the period. Shown as a positive value despite being a cash outflow in the SEC filing.

Fiscal Year Period End Value Filed
FY2024 Feb 22, 2025 $295.10M Apr 21, 2025
FY2024 Feb 24, 2024 $276.20M Apr 21, 2025
FY2024 Feb 25, 2023 $255.10M Apr 21, 2025
FY2023 Feb 26, 2022 $207.40M Apr 22, 2024
FY2022 Feb 27, 2021 $93.70M Apr 25, 2023
FY2022 Feb 29, 2020 $0 Apr 26, 2022
FY2021 Feb 23, 2019 $0 Apr 28, 2021